CVALF
Price
$1.81
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
47.78M
CYYNF
Price
$0.08
Change
-$0.07 (-46.67%)
Updated
Jun 12 closing price
Capitalization
25.05M
Interact to see
Advertisement

CVALF vs CYYNF

Header iconCVALF vs CYYNF Comparison
Open Charts CVALF vs CYYNFBanner chart's image
Covalon Technologies
Price$1.81
Change-$0.00 (-0.00%)
Volume$2.41K
Capitalization47.78M
Cynata Therapeutics
Price$0.08
Change-$0.07 (-46.67%)
Volume$20K
Capitalization25.05M
CVALF vs CYYNF Comparison Chart in %
Loading...
CVALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVALF vs. CYYNF commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVALF is a Hold and CYYNF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (CVALF: $1.81 vs. CYYNF: $0.08)
Brand notoriety: CVALF and CYYNF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVALF: 43% vs. CYYNF: 322%
Market capitalization -- CVALF: $47.78M vs. CYYNF: $25.05M
CVALF [@Biotechnology] is valued at $47.78M. CYYNF’s [@Biotechnology] market capitalization is $25.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVALF’s FA Score shows that 0 FA rating(s) are green whileCYYNF’s FA Score has 1 green FA rating(s).

  • CVALF’s FA Score: 0 green, 5 red.
  • CYYNF’s FA Score: 1 green, 4 red.
According to our system of comparison, CYYNF is a better buy in the long-term than CVALF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVALF’s TA Score shows that 3 TA indicator(s) are bullish while CYYNF’s TA Score has 3 bullish TA indicator(s).

  • CVALF’s TA Score: 3 bullish, 5 bearish.
  • CYYNF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, CYYNF is a better buy in the short-term than CVALF.

Price Growth

CVALF (@Biotechnology) experienced а +9.04% price change this week, while CYYNF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CVALF($47.8M) has a higher market cap than CYYNF($25.1M). CVALF YTD gains are higher at: -19.196 vs. CYYNF (-57.895). CVALF has higher annual earnings (EBITDA): 4.73M vs. CYYNF (-10.8M).
CVALFCYYNFCVALF / CYYNF
Capitalization47.8M25.1M190%
EBITDA4.73M-10.8M-44%
Gain YTD-19.196-57.89533%
P/E Ratio16.55N/A-
Revenue33.8MN/A-
Total Cash18MN/A-
Total Debt609KN/A-
FUNDAMENTALS RATINGS
CVALF vs CYYNF: Fundamental Ratings
CVALF
CYYNF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
32
Undervalued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
5598
PRICE GROWTH RATING
1..100
5796
P/E GROWTH RATING
1..100
93100
SEASONALITY SCORE
1..100
n/a55

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYYNF's Valuation (32) in the null industry is in the same range as CVALF (63). This means that CYYNF’s stock grew similarly to CVALF’s over the last 12 months.

CVALF's Profit vs Risk Rating (69) in the null industry is in the same range as CYYNF (100). This means that CVALF’s stock grew similarly to CYYNF’s over the last 12 months.

CVALF's SMR Rating (55) in the null industry is somewhat better than the same rating for CYYNF (98). This means that CVALF’s stock grew somewhat faster than CYYNF’s over the last 12 months.

CVALF's Price Growth Rating (57) in the null industry is somewhat better than the same rating for CYYNF (96). This means that CVALF’s stock grew somewhat faster than CYYNF’s over the last 12 months.

CVALF's P/E Growth Rating (93) in the null industry is in the same range as CYYNF (100). This means that CVALF’s stock grew similarly to CYYNF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CVALFCYYNF
RSI
ODDS (%)
Bearish Trend 3 days ago
64%
Bullish Trend 3 days ago
38%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
76%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
38%
MACD
ODDS (%)
Bullish Trend 3 days ago
62%
Bearish Trend 4 days ago
46%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
53%
Bullish Trend 3 days ago
19%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
61%
Bearish Trend 3 days ago
30%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
77%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
CVALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANFGF24.73N/A
N/A
Antofagasta plc
JNBYF1.52N/A
N/A
JNBY Design Ltd.
WNDLF97.73N/A
N/A
Wendel
HANCF0.02N/A
N/A
HANSTONE GOLD CORP.
ISVLF0.19-0.01
-4.54%
IMPACT Silver Corp.

CVALF and

Correlation & Price change

A.I.dvisor tells us that CVALF and ARGNF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVALF and ARGNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVALF
1D Price
Change %
CVALF100%
N/A
ARGNF - CVALF
22%
Poorly correlated
N/A
CYDY - CVALF
10%
Poorly correlated
-14.17%
GNMSF - CVALF
9%
Poorly correlated
N/A
FAMDF - CVALF
6%
Poorly correlated
N/A
CYYNF - CVALF
6%
Poorly correlated
N/A
More

CYYNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYYNF has been loosely correlated with HLOSF. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CYYNF jumps, then HLOSF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYYNF
1D Price
Change %
CYYNF100%
N/A
HLOSF - CYYNF
39%
Loosely correlated
N/A
DMAC - CYYNF
30%
Poorly correlated
+0.79%
PALI - CYYNF
21%
Poorly correlated
-1.93%
CVALF - CYYNF
6%
Poorly correlated
N/A
FAMDF - CYYNF
2%
Poorly correlated
N/A
More